Delivery Order SPE2DB22D2206-SPE2DB25FHT10
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,821.52, is for the provision of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023 and is a Firm Fixed Price type contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, and has a ceiling value of $2,665.02. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $8,377.63 and a performance period ending on July 2, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,665.02 firm-fixed-price contract is for the delivery of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS, with a period of performance through May 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,074 units of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has a ceiling value of $3,653.65 and an ultimate completion date of April 5, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a medication, with a ceiling value of $2,175.03. The contract is a firm fixed price type with a performance period ending on May 27, 2025. This award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 1 GM/50 MLS, a type of prescription medication. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $2,286.48. The ultimate completion date for this delivery order is May 20, 2025. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $14,307.57 and a period of performance through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $4,184.38 and a completion date of May 28, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $1,569.55 and a performance period through May 20, 2025. The contract is a firm fixed-price delivery order, indicating specific quantities and pricing. It is not designated as a set-aside contract,...